The rationale behind COX-1/2 degradation in tumor cells was to reduce prostaglandin E2 (PGE2) levels, as this molecule is known to promote immunosuppressive cells, potentially enhancing tumor immunogenicity. Here, PTGS1 is linked to neoplasm.